Cardiac arrest systems of care are successfully coordinating community, emergency medical
services, and hospital efforts to improve the process of care for patients who have had a …

Left ventricular assist devices are becoming an increasingly prevalent therapy for patients
with Stage D heart failure with reduced ejection fraction. Technological advances have …

Background Continuous-flow left ventricular assist systems increase the rate of survival
among patients with advanced heart failure but are associated with the development of …

Background Recommended structured clinical practices including implant technique, anti-
coagulation strategy, and pump speed management (PREVENT [PREVENtion of HeartMate …

Abstract Background: The HeartMate 3 left ventricular assist system (LVAS) is intended to
provide long-term support to patients with advanced heart failure. The centrifugal flow pump …

Carbon nanotubes (CNTs), with unique graphitic structure, superior mechanical, electrical,
optical and biological properties, has attracted more and more interests in biomedical …

Mechanical circulatory support (MCS) evolved from an engineering dream to clinical reality
during the 1980s when increasing numbers of patients were dying on heart transplant wait …

Background The HeartMate 3 left ventricular assist system is engineered to avoid pump
thrombosis, yet bleeding complications persist. We investigated the safety of low-intensity …

Outcomes of heart failure patients supported by a continuous-flow left ventricular assist
device (LVAD) have steadily improved during the past decade, largely due to better patient …

Substantial progress in the field of mechanical circulatory support (MCS) has expanded the
treatment options for patients with advanced-stage heart failure (HF). Currently available …